Palombella Vito J.
Chief Scientific Officer at Surface Oncology, Inc.; Chief Scientific Officer at INFINITY PHARMACEUTICALS, INC.
- Sold, on record
- $1.1M
- Dollars the filings state
- Form 4 sales
- 11
- Latest Aug 3, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Surface Oncology, Inc.Chief Scientific Officer
- INFINITY PHARMACEUTICALS, INC.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- INFINITY PHARMACEUTICALS, INC.57,936 shares
- Surface Oncology, Inc.30,788 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale INFINITY PHARMACEUTICALS, INC.UnusualFeb 25, 2014 2014
Sold 4,736 shares at $15.00 ($71k)
Palombella Vito J., Chief Scientific Officer
Sold 100% of holdings ($71k position)0 shares left1x usual sizeFiling
- 2 Form 4 sale INFINITY PHARMACEUTICALS, INC.UnusualJul 1, 2014 +126 days
Sold 879 shares at $12.87 ($11k)
Palombella Vito J., Chief Scientific Officer
Sold 100% of holdings ($11k position)0 shares left0.2x usual sizeFiling
- 3 Form 4 sale INFINITY PHARMACEUTICALS, INC.UnusualSep 3, 2014 +64 days
Sold 9,472 shares at $15.39 ($146k)
Palombella Vito J., Chief Scientific Officer
Sold 100% of holdings ($146k position)0 shares left2x usual sizeFiling
- 4 Form 4 sale INFINITY PHARMACEUTICALS, INC.UnusualNov 26, 2014 +84 days
Sold 4,736 shares at $15.00 ($71k)
Palombella Vito J., Chief Scientific Officer
Sold 100% of holdings ($71k position)0 shares left1x usual sizeFiling
- 5 Form 4 sale INFINITY PHARMACEUTICALS, INC.UnusualDec 15, 2014 +19 days
Sold 4,737 shares at $16.32 ($77k)
Palombella Vito J., Chief Scientific Officer
Sold 100% of holdings ($77k position)0 shares left1x usual sizeFiling
- 6 Form 4 sale INFINITY PHARMACEUTICALS, INC.UnusualJun 15, 2015 +182 days
Sold 4,737 shares at $10.97 ($52k)
Palombella Vito J., Chief Scientific Officer
Sold 84.5% of holdings ($61k position)868 shares left1x usual sizeFiling
- 7 Form 4 sale Surface Oncology, Inc.UnusualJul 21, 2021 +2228 days
Sold 26,325 shares at $6.10 ($161k)
Palombella Vito J., Chief Scientific Officer
Sold 32.9% of holdings ($488k position)53,675 shares leftFirst sale on recordFiling
- 8 Form 4 sale Surface Oncology, Inc.Plan not statedAug 3, 2022 +378 days
Sold 4,463 shares at $1.72 ($8k)
Palombella Vito J., Chief Scientific Officer
Sold 4.9% of holdings ($158k position)87,212 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2022 | Aug 5, 2022 | Surface Oncology, Inc. | Chief Scientific Officer | Form 4 sale | 4,463 | $8k | 4.9% | Plan not stated | SEC |
| Jul 21, 2021 | Jan 14, 2022 | Surface Oncology, Inc. | Chief Scientific Officer | Form 4 sale | 26,325 | $161k | 32.9% | Unusual | SEC |
| Jun 15, 2015 | Jun 16, 2015 | INFINITY PHARMACEUTICALS, INC. | Chief Scientific Officer | Form 4 sale | 4,737 | $52k | 84.5% | Unusual | SEC |
| Dec 15, 2014 | Dec 16, 2014 | INFINITY PHARMACEUTICALS, INC. | Chief Scientific Officer | Form 4 sale | 4,737 | $77k | 100.0% | Unusual | SEC |
| Nov 26, 2014 | Nov 28, 2014 | INFINITY PHARMACEUTICALS, INC. | Chief Scientific Officer | Form 4 sale | 4,736 | $71k | 100.0% | Unusual | SEC |
| Sep 3, 2014 | Sep 5, 2014 | INFINITY PHARMACEUTICALS, INC. | Chief Scientific Officer | Form 4 sale | 9,472 | $146k | 100.0% | Unusual | SEC |
| Jul 1, 2014 | Jul 2, 2014 | INFINITY PHARMACEUTICALS, INC. | Chief Scientific Officer | Form 4 sale | 879 | $11k | 100.0% | Unusual | SEC |
| Feb 25, 2014 | Feb 27, 2014 | INFINITY PHARMACEUTICALS, INC. | Chief Scientific Officer | Form 4 sale | 4,736 | $71k | 100.0% | Unusual | SEC |
| Jan 2, 2014 | Jan 6, 2014 | INFINITY PHARMACEUTICALS, INC. | Chief Scientific Officer | Form 4 sale | 753 | $10k | 100.0% | Unusual | SEC |
| Sep 27, 2013 | Sep 30, 2013 | INFINITY PHARMACEUTICALS, INC. | Chief Scientific Officer | Form 4 sale | 4,736 | $82k | 100.0% | Unusual | SEC |
| Jun 20, 2013 | Jun 21, 2013 | INFINITY PHARMACEUTICALS, INC. | Chief Scientific Officer | Form 4 sale | 23,150 | $429k | 100.0% | Unusual | SEC |